Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Tevogen Bio Holdings Inc. Director's Dealing 2021

Nov 3, 2021

33780_dirs_2021-11-03_7aeb31c7-396b-42cc-8c79-985e4298f84f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Semper Paratus Acquisition Corp (LGSTU)
CIK: 0001860871
Period of Report: 2021-11-03

Reporting Person: Semper Paratus Sponsor LLC (10% Owner)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Class B ordinary shares, par value $0.0001 per share $ Class A ordinary shares, par value $0.0001 per share (11983333) Direct

Footnotes

F1: As described in the Issuer's registration statement on Form S-1 (No. 333-260113), the shares of Class B ordinary shares will automatically convert into shares of Class A ordinary shares at the time of the Issuer's initial business combination on a one-for-one basis subject to certain adjustments and have no expiration date.

F2: These shares represent the shares of Class B ordinary shares held directly by Semper Paratus Sponsor LLC (the "Sponsor"), acquired pursuant to a subscription agreement by and between the Sponsor and the Issuer. The shares of Class B ordinary shares owned by the Sponsor include up to 1,530,000 shares that are subject to forfeiture in the event the underwriters of the initial public offering of the Issuer's securities do not exercise their over-allotment option in full as described in the Issuer's registration statement.